ACHV Q3 2025 Earnings — Achieve Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

ACHVAchieve Life Sciences, Inc.

$233M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$54,000

Operating Income

-$15M

Net Income

-$14M

EPS (Diluted)

$-0.28

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$52M

Total Liabilities

$18M

Stockholders' Equity

$34M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$54,000	$0	—
Operating Income	-$15M	-$12M	-17.9%
Net Income	-$14M	-$13M	-15.4%